insights_auto
Why is ARX down 4.00%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-4.00%(-0.020) 1D
Nov 16, 4:10:15 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.51
High
A$0.51
Low
A$0.48
Mkt. cap
166.03M
Avg. vol.
288.42K
Volume
185.28K
P/E ratio
45.80
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.51
High
A$0.51
Low
A$0.48
Mkt. cap
166.03M
Avg. vol.
288.42K
Volume
185.28K
P/E ratio
45.80
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
ChartMill
·
21 minutes ago
S&P 500 Premarket Losers on Nov. 16, 2026: COIN, LITE, COHR
marketscreener.com
·
33 minutes ago
BofA Securities Adjusts Nasdaq Price Target to $135 From $133, Maintains Buy Rating
Barron's
·
1 hour ago
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
The Motley Fool
·
1 hour ago
If You Had Invested $10,000 in the Vanguard S&P 500 ETF (VOO) in 2016, Here's What You Would Have Today
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd